Advertisement
Screener

COMPASS THERAPEUTICS, INC. (CMPX) Accrued Professional Fees, Current

2.8 / 5 stars · 68/120 Roast Me

COMPASS THERAPEUTICS, INC. Accrued Professional Fees, Current

COMPASS THERAPEUTICS, INC. (CMPX) had Accrued Professional Fees, Current of $75.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-12.

Discontinued › Notes

us-gaap:AccruedProfessionalFeesCurrent · last filed 2021-11-12

  • 2021-09-30: Accrued Professional Fees, Current $75.00K.
  • 2021-06-30: Accrued Professional Fees, Current $0.00.
  • 2021-03-31: Accrued Professional Fees, Current $196.00K.
  • 2020-12-31: Accrued Professional Fees, Current $326.00K.
Period endAccrued Professional Fees, Current
2021-09-30$75.00K
10-Q · filed 2021-11-12
2021-06-30$0.00
10-Q · filed 2021-08-16
2021-03-31$196.00K
10-Q · filed 2021-04-30
2020-12-31$326.00K
10-Q · filed 2021-11-12
2020-09-30$507.00K
10-Q · filed 2020-11-09
2020-06-30$957.00K
10-Q · filed 2020-08-13
2019-12-31$417.00K
10-K · filed 2021-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alector, Inc. (ALEC)United States$0.213B-1.90
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35